publication venue for
- Desirable impacts on acid reflux and gastric pH 2001
- Diagnostic significance, provocants and time-course of heartburn and regurgitation 2001
- Should acid reflux be abolished in patients with oesophageal columnar metaplasia? 2001
- Symptom status as a surrogate for absence of endoscopic oesophagitis 2001
- Session 4: Long-term medical management 2001
- CYTOKINES AND PEPTIC-ULCER DISEASE 1993
- Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY. 36:704-711. 2024
- Video capsule endoscopy versus computed tomography enterography in assessing suspected small bowel bleeding: a systematic review and diagnostic test accuracy meta-analysis. 35:1253-1262. 2023
- Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis. 35:1131-1136. 2023
- Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis. 35:231-240. 2023
- Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease. 34:1210-1219. 2022
- Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study. 33:e634-e641. 2021
- Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients. 33:1274-1279. 2021
- Impact of donor sodium levels on clinical outcomes in liver transplant recipients: a systematic review. 32:1489-1496. 2020
- Trends in survival based on treatment modality for esophageal cancer: a population-based study. 31:1192-1199. 2019
- Coeliac disease screening in first-degree relatives on the basis of biopsy and genetic risk. 26:263-267. 2014
- A presentation of latent tropical sprue in a Canadian hospital. 25:996-1000. 2013
- Bile acids and coagulation factors. 25:152-158. 2013
- Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. 23:499-506. 2011
- Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. 23:1-1. 2011
- Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. 22:583-590. 2010
- Predictors of persistent gastrointestinal symptoms among new presenters to primary care. 22:296-305. 2010
- Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. 20:1064-1070. 2008
- An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease. 18:349-368. 2006
- Doctor–patient interaction for irritable bowel syndrome in primary care. 16:1161-1166. 2004
- Cost-effectiveness and long-term impact of Helicobacter pylori ???test and treat??? service in reducing open access endoscopy referrals. 16:981-986. 2004
- A glossary of economic terms. 16:563-565. 2004
- A glossary of economic terms. 16:563-565. 2004
- Cost-utility and cost-benefit analyses. 16:527-534. 2004
- Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp Trial. 16:543-549. 2004
- Upper gastrointestinal haemorrhage following cardiac surgery. 16:191-194. 2004
- Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. 14:857-863. 2002
- Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis. 14:429-433. 2002
- Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. 14:249-256. 2002
- Surreptitious abuse of magnesium laxatives as a cause of chronic diarrhoea. 13:599-601. 2001
- Gastric acidity and preneoplastic/neoplastic changes of the stomach.. 12:1353-1354. 2000
- Reply to: Gastric acidity and preneoplastic/neoplastic changes of the stomach. 12:1354-1354. 2000
- Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. 12:257-265. 2000
- The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. 12:165-173. 2000
- The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. 11:1245-1250. 1999
- Do young dyspeptics require endoscopy any more?. 11:S63-S63. 1999
- Should we go further and screen and treat? Discussion III. 11:S73-S73. 1999
- The role of psychological and biological factors in postinfective gut dysfunction. 11:468-471. 1999
- Decision-making in dyspepsia. 11:223-230. 1999
- Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. 9:521-525. 1997
- Do patients need to fast for a 13C-urea breath test?. 9:275-277. 1997
- Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.. 7:835-840. 1995
- Critical issues in the pathophysiology and management of peptic ulcer disease.. 7:685-699. 1995
- Irritable bowel syndrome could be an inflammatory disorder. 6:478-482. 1994
- Helicobacter pylori. 5:963-968. 1993
- Does long-term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease?. 5:311-318. 1993
- Treatment of acute duodenal and pyloric channel ulcers with sucralfate suspension (2 g/10 ml) twice daily. 5:287-292. 1993
- Acid, bacteria and the mucosal barrier: Aspiration or translocation as the cause of pneumonia?. 4:881-884. 1992
- A PROSPECTIVE COMPARISON OF SYMPTOMS AND 5 DIAGNOSTIC-TESTS IN PATIENTS WITH HELICOBACTER-PYLORI POSITIVE AND NEGATIVE DYSPEPSIA. 3:463-468. 1991
- FAMOTIDINE SHOULD BE TAKEN WITH SUPPER - THE EFFECT OF DRUG MEAL INTERACTIONS ON GASTRIC-ACIDITY AND PLASMA FAMOTIDINE LEVELS. 3:405-412. 1991
- A new programmable infusion pump for individual control of intragastric pH: validation and effect of ranitidine. 3:9-13. 1991
- Randomized controlled trials of the medical treatment of cirrhotic ascites. 3:351-359. 1991
- CONTINUOUS LONG-TERM GASTRIC PH-METRY - FURTHER SUGGESTIONS FOR OPTIMIZING DATA-ANALYSIS - REPLY. 2:320-323. 1990
- INJECTION THERAPY IN THE TREATMENT OF UPPER GASTROINTESTINAL HEMORRHAGE. 2:79-86. 1990
- MEDICAL-MANAGEMENT OF GASTROINTESTINAL-BLEEDING. 2:73-78. 1990
- Diagnosis and treatment of gastrointestinal bleeding: When, with what and by whom?: Overview. 2:69-72. 1990
- Review twenty-four-hour intragastric pH-metry studies: Easy to do but difficult to analyse. 1:167-174. 1989